Skip to main content

Table 3 Demographic and laboratory characteristics of the study group by glycemic control

From: Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes

 

Poor glycemic control (n = 592)

Good glycemic control (n = 214)

P value

Age (years), median (range)

12.4 (2.8–18)

11 (2.6–17.72)

0.001*

Sex

• Male

260

98

0.64

• Female

332

116

Age of diabetes onset, median (range)

6.12 (1–14.4)

6 (1–15.1)

0.36

Diabetes duration (years), median (range)

5 (1–17)

4.8 (1–14.7)

0.01*

Insulin dose (U/kg/day), mean ± SD

1.29 ± 0.41

1.24 ± 0.32

0.1

Weight SDS, mean ± SD

− 0.9 ± 1.4

− 0.69 ± 1.5

0.06

Height SDS, mean ± SD

− 1.34 ± 1.2

− 1.42 ± 1.5

0.43

BMI SDS, mean ± SD

− 0.6 ± 1.4

− 0.8 ± 1.3

0.06

TC (mg/dl), mean ± SD

160.42 ± 46.51

145.19 ± 40

<0.001*

TG (mg/dl), mean ± SD

85.7 ± 39.6

78.61 ± 34

0.02*

LDL (mg/dl), mean ± SD

99.5 ± 33.16

93.1 ± 28.8

0.13*

HDL (mg/dl), mean ± SD

52 ± 19.2

51.25 ± 15.25

0.6

HbA1c (%), mean ± SD

6.46 ± 1.52

6.76 ± 0.58

<0.001*

Dyslipidemia, frequency (%)

425 (71.79 %)

143 (66.82 %)

0.17

  1. *P value < 0.05 is considered significant, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein, HbA1c glycosylated hemoglobin, BMI body mass index, SDS standard deviation score